Case Study · Smart Ring Category · 2013-Present

Oura Ring (2013-2026): how a Finnish wearable defined the smart-ring category and reached $5.2B then $11B valuation

Oura was founded in 2013 in Oulu, Finland. The product is a ring-format wearable that tracks sleep, heart rate, body temperature, and activity. For its first several years Oura was a niche product favored by biohackers, athletes, and early-adopter health-conscious consumers. In 2020 it became a category-defining wearable when the NBA bubble adopted it for COVID monitoring. Through 2024-2025 distribution expanded to mass retail (Target, Amazon) and the Oura Ring 4 launched. Oura sold 1.3 million rings in 2024 alone (more than half of the 5.5 million total rings ever sold), generating approximately $500 million in revenue. The December 2024 Series D valued the company at $5.2 billion; the October 2025 follow-on round valued it at approximately $11 billion. The case is the canonical smart-ring category-creation story.

TL;DR — the quick read
  • Story: Oura Ring smart ring wearable founded 2013 in Finland. Measures sleep, recovery, activity, HRV, temperature. Celebrities (Prince Harry, Kim Kardashian) adopted. Peak valuation >$2.55B in 2022. Dominant smart-ring category position. Subscription model post-2021.
  • Why it matters: Oura is a defining smart-ring category case — demonstrating form-factor differentiation can create new wearable categories with specific use cases driving adoption.
  • Takeaway: Form-factor differentiation can create new wearable categories.
  • Takeaway: Specific use cases (sleep tracking, health metrics) drive adoption better than general fitness positioning.
  • Takeaway: Subscription-plus-hardware model is increasingly standard in premium wearables.
STAR framework

Oura Ring smart ring — the four-step story

S
Situation
Situation
Wearables in 2013 were dominated by wrist devices (Fitbit, later Apple Watch). Sleep tracking and health metrics had limited continuous-wear options.
T
Task
Task
Build smart ring wearable with sleep and health metric focus.
A
Action
Action
Founded 2013 in Finland. Ring form factor with sleep, recovery, activity, HRV, temperature metrics. Celebrity adoption 2020+. Subscription model post-2021.
R
Result
Result
Peak valuation >$2.55B in 2022. Dominant smart-ring category position. Defining form-factor differentiation success.
By the Numbers

Oura Ring by the numbers

0
Oura founded
Finland
Source: Oura history
0
Distinctive form factor
vs. wrist wearables
Source: Product differentiation
$0-$549
Device pricing range
Plus subscription
Source: Oura pricing
$0/mo
Subscription
Post-2021 membership
Source: Oura pricing
>$0B
Peak valuation 2022
Funding round
Source: Press reporting
0
Adoption drivers
Prince Harry, Kardashians, others
Source: Public reporting

Quick facts

CompanyOura Health Oy (Finland)
Founded2013 in Oulu, Finland
Co-founder and CEO (current)Tom Hale (CEO since 2023)
Original foundersPetteri Lahtela, Markku Koskela, Kari Kivela
ProductSmart ring tracking sleep, HRV, body temperature, activity, recovery
2024 rings sold~1.3 million (more than half of 5.5M total ever sold)
2024 revenue~$500 million (~80% hardware, ~20% subscription)
Paying subscribers (2024)~2 million ($6/month)
Series D (December 2024)$200M led by Fidelity at $5.2B valuation; Dexcom $75M strategic
October 2025 round$900M led by Fidelity at ~$11B valuation
Honest note
Revenue and subscriber figures come from Sacra (secondary-market analyst) and TechCrunch/Fierce Healthcare coverage rather than from audited Oura disclosures. The company is privately held. Competitive risk has increased as Samsung launched the Galaxy Ring in 2024 and other entrants (RingConn, Ultrahuman) have released products. Apple has not yet released a ring product but is widely expected to enter the category at some point. The category-creation case is settled; the long-term defensibility against larger consumer electronics players is the open question.

The 2013 founding and early years

Oura was founded in 2013 in Oulu, Finland by Petteri Lahtela, Markku Koskela, and Kari Kivela. The team had backgrounds in sensor technology and embedded electronics. The product thesis was specific: existing wrist-based wearables (Fitbit, Apple Watch) were optimised for activity tracking but were not optimal for sleep tracking and continuous body-state monitoring because of wrist motion, fit, and battery life. A ring form factor could provide more accurate sleep and resting-physiology data with less user friction.

For the first six years (2013-2019), Oura sold to a niche audience: biohackers, professional athletes, sleep researchers, and early-adopter health-conscious consumers. The Oura Ring 2 launched in 2018, the Ring 3 in 2021. Revenue was modest. The brand was credible among health-data enthusiasts but had not crossed into mainstream consumer awareness.

The 2020 inflection: NBA bubble and pandemic monitoring

The 2020 NBA bubble (the COVID-isolated continuation of the 2019-2020 season at Walt Disney World) adopted Oura rings for player and staff temperature monitoring. The choice was practical — the ring form factor and continuous-temperature capability fit the use case — but the visibility was strategic. Major sports leagues, military programs, and corporate wellness programs followed. Through 2020-2021 demand outstripped supply, and brand awareness expanded beyond the early-adopter niche.

The Oura Ring 3 launched in November 2021 with subscription-based premium features (advanced insights, period-prediction, daily health scores). The subscription model was structurally important — it converted a one-time hardware purchase into recurring revenue and improved the unit economics that the early Oura Ring 2 had not supported.

The 2024 mass-market push and $5.2B / $11B valuations

In April 2024 Oura entered mass retail with distribution at Target and Amazon. In October 2024 the Oura Ring 4 launched. The combination produced a step-change in sales: 1.3 million rings sold in 2024 alone, more than half of all 5.5 million rings ever sold. Total 2024 revenue reached approximately $500 million (roughly $390M hardware plus $110M subscription from 2 million paying subscribers).

The December 2024 Series D round (led by Fidelity, with strategic participation from Dexcom) valued the company at $5.2 billion. A subsequent October 2025 round led by Fidelity raised $900 million at approximately $11 billion valuation. The progression from niche biohacker product to $11B+ valued category-defining wearable took roughly four years from the 2020 inflection.

How RGM thinks about category-creation wearables

When clients ask about category-creation in consumer electronics, the Oura case is a useful current example of a multi-year build-up before the inflection. Three structural lessons. First, the product was correctly positioned for the use case (sleep and continuous physiology) from the start, even if mass-market awareness was years away. Second, the inflection moment (NBA bubble, pandemic) was external and unpredictable, but the product was ready to seize it because Lahtela and the team had spent years on the underlying sensor and battery technology. Third, the post-inflection execution — subscription model (2021), Ring 4 launch (2024), mass retail distribution (2024) — converted the awareness moment into sustained growth.

The pattern is hard to copy. Competing in consumer wearables now requires either accepting that you are entering an already-defined category (Samsung Galaxy Ring, Ultrahuman, RingConn) or finding a different form factor or use case that has not been claimed. Apple is widely expected to enter the smart-ring category eventually and would be a significant competitive presence. Oura's defensibility going forward depends on product-data advantages from its five-million-plus installed ring base and on its category leadership translating into sustained mind-share against larger consumer electronics players.

Frequently asked questions

When was Oura founded?

2013 in Oulu, Finland, by Petteri Lahtela, Markku Koskela, and Kari Kivela. The team had backgrounds in sensor technology and embedded electronics, with the product thesis that a ring form factor would produce more accurate sleep and continuous-physiology data than wrist-based wearables.

How big is Oura now?

Approximately $500 million in 2024 revenue with 2 million paying subscribers and 1.3 million rings sold in 2024 alone. The October 2025 funding round valued the company at approximately $11 billion. Cumulative ring sales reached 5.5 million by late 2024, more than half of which were sold in 2024.

What was the inflection moment?

The 2020 NBA bubble adopted Oura rings for player and staff temperature monitoring during the COVID-isolated continuation of the 2019-2020 season. The visibility brought Oura into mainstream consumer awareness; subsequent partnerships with major sports leagues, military programs, and corporate wellness programs accelerated growth. The Oura Ring 3 launch in November 2021 with subscription premium features converted the awareness into recurring revenue.

Who are the competitors?

Samsung launched the Galaxy Ring in 2024, becoming the most significant large-player entrant. Smaller competitors include RingConn, Ultrahuman, and others. Apple has not yet released a ring product but is widely expected to enter the category at some point. Defensibility against larger consumer-electronics entrants is the open strategic question for Oura.

How does Oura make money?

Approximately 80 percent hardware (ring sales, typically $349-$499 depending on model and finish) and 20 percent subscription. The Oura Membership subscription is $6 per month and unlocks the full set of features and historical data. The subscription model launched with the Ring 3 in November 2021 and has been important to unit economics; paying subscribers reached 2 million in 2024.

Why Dexcom as a strategic investor?

Dexcom is the continuous-glucose-monitor (CGM) market leader. The strategic logic is that continuous-physiology data (sleep, heart rate, body temperature) from Oura combined with continuous-glucose data from Dexcom could form a more comprehensive continuous-health-monitoring platform than either product alone. The $75 million strategic investment alongside the December 2024 Series D was structured to support that partnership.

Sources & references

Related